The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer

De Wei Wu, Po Lin Lin, Lee Wang, Chi Chou Huang, Huei Lee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The mechanism underlying tumor aggressiveness and cetuximab (CTX) resistance in KRAS-wild-type (KRAS -WT) colorectal cancer remains obscure. We here provide evidence that DDX3 promoted soft agar growth and invasiveness of KRAS-WT cells, as already confirmed in KRAS-mutated cells. Mechanistically, increased KRAS expression induced ROS production, which elevated HIF-1a and YAP1 expression. Increased HIF-1a persistently promoted DDX3 expression via a KRAS/ROS/HIF-1a feedback loop. DDX3-mediated aggressiveness and CTX resistance were regulated by the YAP1/SIX2 axis in KRAS-WT cells and further confirmed in animal models. Kaplan-Meier and Cox regression analysis indicated that DDX3, KRAS, and YAP1 expression had prognostic value for OS and RFS in KRAS-WT and KRAS-mutated tumors, but SIX2 and YAP1/SIX2 were prognostic value only in KRAS-WT patients. The observation from patients seemed to support the mechanistic action of cell and animal models. We therefore suggest that combining YAP1 inhibitors with CTX may therefore suppress DDX3-mediated tumor aggressiveness and enhance CTX sensitivity in KRAS-WT colorectal cancer.

Original languageEnglish
Pages (from-to)1114-1132
Number of pages19
JournalTheranostics
Volume7
Issue number5
DOIs
Publication statusPublished - 2017

Fingerprint

Colorectal Neoplasms
Neoplasms
Animal Models
Agar
Regression Analysis
Observation
Cetuximab
Growth

Keywords

  • Colorectal cancer
  • DDX3
  • KRAS
  • SIX2
  • YAP1

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer. / Wu, De Wei; Lin, Po Lin; Wang, Lee; Huang, Chi Chou; Lee, Huei.

In: Theranostics, Vol. 7, No. 5, 2017, p. 1114-1132.

Research output: Contribution to journalArticle

Wu, De Wei ; Lin, Po Lin ; Wang, Lee ; Huang, Chi Chou ; Lee, Huei. / The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer. In: Theranostics. 2017 ; Vol. 7, No. 5. pp. 1114-1132.
@article{3a480f20299d4ac687228db37cd10752,
title = "The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer",
abstract = "The mechanism underlying tumor aggressiveness and cetuximab (CTX) resistance in KRAS-wild-type (KRAS -WT) colorectal cancer remains obscure. We here provide evidence that DDX3 promoted soft agar growth and invasiveness of KRAS-WT cells, as already confirmed in KRAS-mutated cells. Mechanistically, increased KRAS expression induced ROS production, which elevated HIF-1a and YAP1 expression. Increased HIF-1a persistently promoted DDX3 expression via a KRAS/ROS/HIF-1a feedback loop. DDX3-mediated aggressiveness and CTX resistance were regulated by the YAP1/SIX2 axis in KRAS-WT cells and further confirmed in animal models. Kaplan-Meier and Cox regression analysis indicated that DDX3, KRAS, and YAP1 expression had prognostic value for OS and RFS in KRAS-WT and KRAS-mutated tumors, but SIX2 and YAP1/SIX2 were prognostic value only in KRAS-WT patients. The observation from patients seemed to support the mechanistic action of cell and animal models. We therefore suggest that combining YAP1 inhibitors with CTX may therefore suppress DDX3-mediated tumor aggressiveness and enhance CTX sensitivity in KRAS-WT colorectal cancer.",
keywords = "Colorectal cancer, DDX3, KRAS, SIX2, YAP1",
author = "Wu, {De Wei} and Lin, {Po Lin} and Lee Wang and Huang, {Chi Chou} and Huei Lee",
year = "2017",
doi = "10.7150/thno.18175",
language = "English",
volume = "7",
pages = "1114--1132",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "5",

}

TY - JOUR

T1 - The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer

AU - Wu, De Wei

AU - Lin, Po Lin

AU - Wang, Lee

AU - Huang, Chi Chou

AU - Lee, Huei

PY - 2017

Y1 - 2017

N2 - The mechanism underlying tumor aggressiveness and cetuximab (CTX) resistance in KRAS-wild-type (KRAS -WT) colorectal cancer remains obscure. We here provide evidence that DDX3 promoted soft agar growth and invasiveness of KRAS-WT cells, as already confirmed in KRAS-mutated cells. Mechanistically, increased KRAS expression induced ROS production, which elevated HIF-1a and YAP1 expression. Increased HIF-1a persistently promoted DDX3 expression via a KRAS/ROS/HIF-1a feedback loop. DDX3-mediated aggressiveness and CTX resistance were regulated by the YAP1/SIX2 axis in KRAS-WT cells and further confirmed in animal models. Kaplan-Meier and Cox regression analysis indicated that DDX3, KRAS, and YAP1 expression had prognostic value for OS and RFS in KRAS-WT and KRAS-mutated tumors, but SIX2 and YAP1/SIX2 were prognostic value only in KRAS-WT patients. The observation from patients seemed to support the mechanistic action of cell and animal models. We therefore suggest that combining YAP1 inhibitors with CTX may therefore suppress DDX3-mediated tumor aggressiveness and enhance CTX sensitivity in KRAS-WT colorectal cancer.

AB - The mechanism underlying tumor aggressiveness and cetuximab (CTX) resistance in KRAS-wild-type (KRAS -WT) colorectal cancer remains obscure. We here provide evidence that DDX3 promoted soft agar growth and invasiveness of KRAS-WT cells, as already confirmed in KRAS-mutated cells. Mechanistically, increased KRAS expression induced ROS production, which elevated HIF-1a and YAP1 expression. Increased HIF-1a persistently promoted DDX3 expression via a KRAS/ROS/HIF-1a feedback loop. DDX3-mediated aggressiveness and CTX resistance were regulated by the YAP1/SIX2 axis in KRAS-WT cells and further confirmed in animal models. Kaplan-Meier and Cox regression analysis indicated that DDX3, KRAS, and YAP1 expression had prognostic value for OS and RFS in KRAS-WT and KRAS-mutated tumors, but SIX2 and YAP1/SIX2 were prognostic value only in KRAS-WT patients. The observation from patients seemed to support the mechanistic action of cell and animal models. We therefore suggest that combining YAP1 inhibitors with CTX may therefore suppress DDX3-mediated tumor aggressiveness and enhance CTX sensitivity in KRAS-WT colorectal cancer.

KW - Colorectal cancer

KW - DDX3

KW - KRAS

KW - SIX2

KW - YAP1

UR - http://www.scopus.com/inward/record.url?scp=85014716145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014716145&partnerID=8YFLogxK

U2 - 10.7150/thno.18175

DO - 10.7150/thno.18175

M3 - Article

C2 - 28435452

AN - SCOPUS:85014716145

VL - 7

SP - 1114

EP - 1132

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 5

ER -